The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Lucid Diagnostics Inc (NASDAQ: LUCD) closed at $1.15 in the last session, down -1.71% from day before closing price of $1.17. In other words, the price has decreased by -$1.71 from its previous closing price. On the day, 0.7 million shares were traded. LUCD stock price reached its highest trading level at $1.195 during the session, while it also had its lowest trading level at $1.14.
Ratios:
We take a closer look at LUCD’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.72 and its Current Ratio is at 0.75.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Ascendiant Capital Markets on December 27, 2021, initiated with a Buy rating and assigned the stock a target price of $16.
On November 08, 2021, Needham started tracking the stock assigning a Buy rating and target price of $17.
On November 08, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $21.Cantor Fitzgerald initiated its Overweight rating on November 08, 2021, with a $21 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 20 ’25 when Matheis Dennis bought 187,098 shares for $1.29 per share. The transaction valued at 242,292 led to the insider holds 187,098 shares of the business.
Matheis Dennis bought 129,684 shares of LUCD for $171,520 on May 21 ’25. The Director now owns 316,782 shares after completing the transaction at $1.32 per share. On May 22 ’25, another insider, Matheis Dennis, who serves as the Director of the company, bought 33,218 shares for $1.32 each. As a result, the insider paid 43,795 and bolstered with 350,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LUCD now has a Market Capitalization of 124424248 and an Enterprise Value of 180469456. For the stock, the TTM Price-to-Sale (P/S) ratio is 29.84. Its current Enterprise Value per Revenue stands at 43.247 whereas that against EBITDA is -3.851.
Stock Price History:
The Beta on a monthly basis for LUCD is 1.25, which has changed by 0.47435892 over the last 52 weeks, in comparison to a change of 0.12632763 over the same period for the S&P500. Over the past 52 weeks, LUCD has reached a high of $1.80, while it has fallen to a 52-week low of $0.72. The 50-Day Moving Average of the stock is -9.56%, while the 200-Day Moving Average is calculated to be 4.59%.
Shares Statistics:
According to the various share statistics, LUCD traded on average about 1.34M shares per day over the past 3-months and 1892370 shares per day over the past 10 days. A total of 84.37M shares are outstanding, with a floating share count of 40.34M. Insiders hold about 62.71% of the company’s shares, while institutions hold 9.78% stake in the company. Shares short for LUCD as of 1749772800 were 1656077 with a Short Ratio of 1.23, compared to 1747267200 on 1779213. Therefore, it implies a Short% of Shares Outstanding of 1656077 and a Short% of Float of 2.31.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
